Global Drug Eluting Stents (DES) Market Research Report 2025(Status and Outlook)
Description
Report Overview
Drug Eluting Stents (DES) are medical devices used in the treatment of coronary artery disease. These stents are designed to prevent restenosis, which is the re-narrowing of the arteries after a stent has been inserted. DES are coated with medication that is slowly released into the surrounding tissue, helping to reduce inflammation and inhibit cell proliferation. This innovative technology has significantly improved the outcomes of patients undergoing coronary artery stenting procedures by reducing the need for repeat interventions.
The market for Drug Eluting Stents (DES) is experiencing steady growth due to several key market trends and drivers. One major trend is the increasing prevalence of coronary artery disease worldwide, driven by factors such as aging populations, sedentary lifestyles, and unhealthy dietary habits. As a result, there is a growing demand for minimally invasive treatment options like DES. Additionally, advancements in stent design and drug coatings are improving the efficacy and safety of DES, further driving market growth. Moreover, the rising adoption of DES in emerging markets, along with increasing investments in healthcare infrastructure, is expected to fuel market expansion. At the same time, ongoing research and development efforts aimed at enhancing the performance of DES are likely to open up new opportunities for market players.
The global Drug Eluting Stents (DES) market size was estimated at USD 1563 million in 2024 and is projected to reach USD 2808.39 million by 2033, exhibiting a CAGR of 7.60% during the forecast period.
This report provides a deep insight into the global Drug Eluting Stents (DES) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc. In terms of regional markets, the report details the market space and development potential of each market segment in North America, Europe, Asia Pacific, South America, the Middle East and Africa, as well as the competitive landscape of major players, etc
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Eluting Stents (DES) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Eluting Stents (DES) market in any manner.
Global Drug Eluting Stents (DES) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market Segmentation (by Type)
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Market Segmentation (by Application)
Coronary Heart Disease
Clinical
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Eluting Stents (DES) Market
Overview of the regional outlook of the Drug Eluting Stents (DES) Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Eluting Stents (DES) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug Eluting Stents (DES), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Drug Eluting Stents (DES) are medical devices used in the treatment of coronary artery disease. These stents are designed to prevent restenosis, which is the re-narrowing of the arteries after a stent has been inserted. DES are coated with medication that is slowly released into the surrounding tissue, helping to reduce inflammation and inhibit cell proliferation. This innovative technology has significantly improved the outcomes of patients undergoing coronary artery stenting procedures by reducing the need for repeat interventions.
The market for Drug Eluting Stents (DES) is experiencing steady growth due to several key market trends and drivers. One major trend is the increasing prevalence of coronary artery disease worldwide, driven by factors such as aging populations, sedentary lifestyles, and unhealthy dietary habits. As a result, there is a growing demand for minimally invasive treatment options like DES. Additionally, advancements in stent design and drug coatings are improving the efficacy and safety of DES, further driving market growth. Moreover, the rising adoption of DES in emerging markets, along with increasing investments in healthcare infrastructure, is expected to fuel market expansion. At the same time, ongoing research and development efforts aimed at enhancing the performance of DES are likely to open up new opportunities for market players.
The global Drug Eluting Stents (DES) market size was estimated at USD 1563 million in 2024 and is projected to reach USD 2808.39 million by 2033, exhibiting a CAGR of 7.60% during the forecast period.
This report provides a deep insight into the global Drug Eluting Stents (DES) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc. In terms of regional markets, the report details the market space and development potential of each market segment in North America, Europe, Asia Pacific, South America, the Middle East and Africa, as well as the competitive landscape of major players, etc
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Eluting Stents (DES) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Eluting Stents (DES) market in any manner.
Global Drug Eluting Stents (DES) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market Segmentation (by Type)
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Market Segmentation (by Application)
Coronary Heart Disease
Clinical
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Eluting Stents (DES) Market
Overview of the regional outlook of the Drug Eluting Stents (DES) Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Eluting Stents (DES) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug Eluting Stents (DES), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
188 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Drug Eluting Stents (DES)
- 1.2 Key Market Segments
- 1.2.1 Drug Eluting Stents (DES) Segment by Type
- 1.2.2 Drug Eluting Stents (DES) Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Drug Eluting Stents (DES) Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Drug Eluting Stents (DES) Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Drug Eluting Stents (DES) Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Drug Eluting Stents (DES) Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Drug Eluting Stents (DES) Product Life Cycle
- 3.3 Global Drug Eluting Stents (DES) Sales by Manufacturers (2020-2025)
- 3.4 Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Drug Eluting Stents (DES) Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers Drug Eluting Stents (DES) Manufacturing Sites, Area Served, Product Type
- 3.8 Drug Eluting Stents (DES) Market Competitive Situation and Trends
- 3.8.1 Drug Eluting Stents (DES) Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Drug Eluting Stents (DES) Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Drug Eluting Stents (DES) Industry Chain Analysis
- 4.1 Drug Eluting Stents (DES) Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Drug Eluting Stents (DES) Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 Global Trade Frictions and Their Impacts to Drug Eluting Stents (DES) Market
- 5.7 ESG Ratings of Leading Companies
- 6 Drug Eluting Stents (DES) Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Drug Eluting Stents (DES) Sales Market Share by Type (2020-2025)
- 6.3 Global Drug Eluting Stents (DES) Market Size Market Share by Type (2020-2025)
- 6.4 Global Drug Eluting Stents (DES) Price by Type (2020-2025)
- 7 Drug Eluting Stents (DES) Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Drug Eluting Stents (DES) Market Sales by Application (2020-2025)
- 7.3 Global Drug Eluting Stents (DES) Market Size (M USD) by Application (2020-2025)
- 7.4 Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
- 8 Drug Eluting Stents (DES) Market Sales by Region
- 8.1 Global Drug Eluting Stents (DES) Sales by Region
- 8.1.1 Global Drug Eluting Stents (DES) Sales by Region
- 8.1.2 Global Drug Eluting Stents (DES) Sales Market Share by Region
- 8.2 Global Drug Eluting Stents (DES) Market Size by Region
- 8.2.1 Global Drug Eluting Stents (DES) Market Size by Region
- 8.2.2 Global Drug Eluting Stents (DES) Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Drug Eluting Stents (DES) Sales by Country
- 8.3.2 North America Drug Eluting Stents (DES) Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Drug Eluting Stents (DES) Sales by Country
- 8.4.2 Europe Drug Eluting Stents (DES) Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Drug Eluting Stents (DES) Sales by Region
- 8.5.2 Asia Pacific Drug Eluting Stents (DES) Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Drug Eluting Stents (DES) Sales by Country
- 8.6.2 South America Drug Eluting Stents (DES) Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Drug Eluting Stents (DES) Sales by Region
- 8.7.2 Middle East and Africa Drug Eluting Stents (DES) Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Drug Eluting Stents (DES) Market Production by Region
- 9.1 Global Production of Drug Eluting Stents (DES) by Region(2020-2025)
- 9.2 Global Drug Eluting Stents (DES) Revenue Market Share by Region (2020-2025)
- 9.3 Global Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Drug Eluting Stents (DES) Production
- 9.4.1 North America Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
- 9.4.2 North America Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Drug Eluting Stents (DES) Production
- 9.5.1 Europe Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
- 9.5.2 Europe Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Drug Eluting Stents (DES) Production (2020-2025)
- 9.6.1 Japan Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
- 9.6.2 Japan Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Drug Eluting Stents (DES) Production (2020-2025)
- 9.7.1 China Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
- 9.7.2 China Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Abbott Vascular
- 10.1.1 Abbott Vascular Basic Information
- 10.1.2 Abbott Vascular Drug Eluting Stents (DES) Product Overview
- 10.1.3 Abbott Vascular Drug Eluting Stents (DES) Product Market Performance
- 10.1.4 Abbott Vascular Business Overview
- 10.1.5 Abbott Vascular SWOT Analysis
- 10.1.6 Abbott Vascular Recent Developments
- 10.2 Advantec Vascular
- 10.2.1 Advantec Vascular Basic Information
- 10.2.2 Advantec Vascular Drug Eluting Stents (DES) Product Overview
- 10.2.3 Advantec Vascular Drug Eluting Stents (DES) Product Market Performance
- 10.2.4 Advantec Vascular Business Overview
- 10.2.5 Advantec Vascular SWOT Analysis
- 10.2.6 Advantec Vascular Recent Developments
- 10.3 B.Braun Melsengen AG
- 10.3.1 B.Braun Melsengen AG Basic Information
- 10.3.2 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
- 10.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Market Performance
- 10.3.4 B.Braun Melsengen AG Business Overview
- 10.3.5 B.Braun Melsengen AG SWOT Analysis
- 10.3.6 B.Braun Melsengen AG Recent Developments
- 10.4 Biosensors
- 10.4.1 Biosensors Basic Information
- 10.4.2 Biosensors Drug Eluting Stents (DES) Product Overview
- 10.4.3 Biosensors Drug Eluting Stents (DES) Product Market Performance
- 10.4.4 Biosensors Business Overview
- 10.4.5 Biosensors Recent Developments
- 10.5 Biotronik
- 10.5.1 Biotronik Basic Information
- 10.5.2 Biotronik Drug Eluting Stents (DES) Product Overview
- 10.5.3 Biotronik Drug Eluting Stents (DES) Product Market Performance
- 10.5.4 Biotronik Business Overview
- 10.5.5 Biotronik Recent Developments
- 10.6 Blue Medical
- 10.6.1 Blue Medical Basic Information
- 10.6.2 Blue Medical Drug Eluting Stents (DES) Product Overview
- 10.6.3 Blue Medical Drug Eluting Stents (DES) Product Market Performance
- 10.6.4 Blue Medical Business Overview
- 10.6.5 Blue Medical Recent Developments
- 10.7 Boston Scientific
- 10.7.1 Boston Scientific Basic Information
- 10.7.2 Boston Scientific Drug Eluting Stents (DES) Product Overview
- 10.7.3 Boston Scientific Drug Eluting Stents (DES) Product Market Performance
- 10.7.4 Boston Scientific Business Overview
- 10.7.5 Boston Scientific Recent Developments
- 10.8 DISA Vascular
- 10.8.1 DISA Vascular Basic Information
- 10.8.2 DISA Vascular Drug Eluting Stents (DES) Product Overview
- 10.8.3 DISA Vascular Drug Eluting Stents (DES) Product Market Performance
- 10.8.4 DISA Vascular Business Overview
- 10.8.5 DISA Vascular Recent Developments
- 10.9 Essen
- 10.9.1 Essen Basic Information
- 10.9.2 Essen Drug Eluting Stents (DES) Product Overview
- 10.9.3 Essen Drug Eluting Stents (DES) Product Market Performance
- 10.9.4 Essen Business Overview
- 10.9.5 Essen Recent Developments
- 10.10 Medtronic Vascular
- 10.10.1 Medtronic Vascular Basic Information
- 10.10.2 Medtronic Vascular Drug Eluting Stents (DES) Product Overview
- 10.10.3 Medtronic Vascular Drug Eluting Stents (DES) Product Market Performance
- 10.10.4 Medtronic Vascular Business Overview
- 10.10.5 Medtronic Vascular Recent Developments
- 10.11 MicroPort Medical
- 10.11.1 MicroPort Medical Basic Information
- 10.11.2 MicroPort Medical Drug Eluting Stents (DES) Product Overview
- 10.11.3 MicroPort Medical Drug Eluting Stents (DES) Product Market Performance
- 10.11.4 MicroPort Medical Business Overview
- 10.11.5 MicroPort Medical Recent Developments
- 10.12 MIV Therapeutics
- 10.12.1 MIV Therapeutics Basic Information
- 10.12.2 MIV Therapeutics Drug Eluting Stents (DES) Product Overview
- 10.12.3 MIV Therapeutics Drug Eluting Stents (DES) Product Market Performance
- 10.12.4 MIV Therapeutics Business Overview
- 10.12.5 MIV Therapeutics Recent Developments
- 10.13 Orbusneich
- 10.13.1 Orbusneich Basic Information
- 10.13.2 Orbusneich Drug Eluting Stents (DES) Product Overview
- 10.13.3 Orbusneich Drug Eluting Stents (DES) Product Market Performance
- 10.13.4 Orbusneich Business Overview
- 10.13.5 Orbusneich Recent Developments
- 10.14 Promed Medical
- 10.14.1 Promed Medical Basic Information
- 10.14.2 Promed Medical Drug Eluting Stents (DES) Product Overview
- 10.14.3 Promed Medical Drug Eluting Stents (DES) Product Market Performance
- 10.14.4 Promed Medical Business Overview
- 10.14.5 Promed Medical Recent Developments
- 10.15 Relisys Medical
- 10.15.1 Relisys Medical Basic Information
- 10.15.2 Relisys Medical Drug Eluting Stents (DES) Product Overview
- 10.15.3 Relisys Medical Drug Eluting Stents (DES) Product Market Performance
- 10.15.4 Relisys Medical Business Overview
- 10.15.5 Relisys Medical Recent Developments
- 10.16 Reva Medical
- 10.16.1 Reva Medical Basic Information
- 10.16.2 Reva Medical Drug Eluting Stents (DES) Product Overview
- 10.16.3 Reva Medical Drug Eluting Stents (DES) Product Market Performance
- 10.16.4 Reva Medical Business Overview
- 10.16.5 Reva Medical Recent Developments
- 10.17 Sahajanand
- 10.17.1 Sahajanand Basic Information
- 10.17.2 Sahajanand Drug Eluting Stents (DES) Product Overview
- 10.17.3 Sahajanand Drug Eluting Stents (DES) Product Market Performance
- 10.17.4 Sahajanand Business Overview
- 10.17.5 Sahajanand Recent Developments
- 10.18 Sino Medical
- 10.18.1 Sino Medical Basic Information
- 10.18.2 Sino Medical Drug Eluting Stents (DES) Product Overview
- 10.18.3 Sino Medical Drug Eluting Stents (DES) Product Market Performance
- 10.18.4 Sino Medical Business Overview
- 10.18.5 Sino Medical Recent Developments
- 10.19 Sorin
- 10.19.1 Sorin Basic Information
- 10.19.2 Sorin Drug Eluting Stents (DES) Product Overview
- 10.19.3 Sorin Drug Eluting Stents (DES) Product Market Performance
- 10.19.4 Sorin Business Overview
- 10.19.5 Sorin Recent Developments
- 10.20 Terumo Medical
- 10.20.1 Terumo Medical Basic Information
- 10.20.2 Terumo Medical Drug Eluting Stents (DES) Product Overview
- 10.20.3 Terumo Medical Drug Eluting Stents (DES) Product Market Performance
- 10.20.4 Terumo Medical Business Overview
- 10.20.5 Terumo Medical Recent Developments
- 11 Drug Eluting Stents (DES) Market Forecast by Region
- 11.1 Global Drug Eluting Stents (DES) Market Size Forecast
- 11.2 Global Drug Eluting Stents (DES) Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Drug Eluting Stents (DES) Market Size Forecast by Country
- 11.2.3 Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region
- 11.2.4 South America Drug Eluting Stents (DES) Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Drug Eluting Stents (DES) by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Drug Eluting Stents (DES) Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Drug Eluting Stents (DES) by Type (2026-2033)
- 12.1.2 Global Drug Eluting Stents (DES) Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Drug Eluting Stents (DES) by Type (2026-2033)
- 12.2 Global Drug Eluting Stents (DES) Market Forecast by Application (2026-2033)
- 12.2.1 Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application
- 12.2.2 Global Drug Eluting Stents (DES) Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
